|
FACA Committee Purpose & Justification
Strategic_Plan
Start: 2010-10-01, End: 2011-09-30, Publication: 2013-07-09 Source: http://explore.data.gov/resource/datasets/c5i3-bb9j
The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML
Part 1, Strategic Plan, format.
Fiscal Year:2011 Committee Type: Scientific Technical Program Advisory Board
Submitter:
Name:Gannon (J.) Dick
Email:gannon_dick@yahoo.com
Organization:
Name:Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
Acronym:HHS
Description: [878]: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/default.htm
Stakeholder(s):
- Department of Health and Human Services: [32]: http://www.hhs.gov/
- Sponsoring Agency (Beneficiary)
- Dr Mukul Agrawal PhD: Roxane Laboratories, Inc
- Committee Member (Performer): Representative
- Jessie L-S Au PhD: Distinguished University Professor, The Ohio State University
- Committee Member (Performer): Special Government Employee (SGE)
- Jeffrey S. Barrett Ph.D.: Associate Professor, Pediatrics, Children's Hospital of Philadelphia
- Committee Member (Performer): Special Government Employee (SGE)
- Prabir K. Basu Ph.D., MBA: Executive Director, National Insitute for Technology and Education
- Committee Member (Performer): Special Government Employee (SGE)
- Michael D. Caldwell M.D., Ph.D: Director, Wound Healing Program, Marshfield Clinic Research Foundation
- Committee Member (Performer): Special Government Employee (SGE)
- Edmund V. Capparelli Pharm.D.: Associate Clinical Professor, Pediatric Pharmacology Research Unit, University of California, San Diego,
- Committee Member (Performer): Special Government Employee (SGE)
- Jerry M. Collins Ph.D.: Associate Director for Developmental Therapeutics, NCI, NIH, Division of Cancer Treatment and Diagnosis
- Committee Member (Performer): Regular Government Employee (RGE)
- David A. Flockhart Ph.D.: Professor and Chief, Division of Clinical Pharmacology, Indiana University
- Committee Member (Performer): Special Government Employee (SGE)
- Kathleen M. Giacomini Ph.D.: Chair, Dept. of Biopharmaceutical Sciences, University of California School of Pharmacy
- Committee Member (Performer): Special Government Employee (SGE)
- Merrill Goozner: Director of Integrity and Science Project, Washington, D.C.
- Committee Member (Performer): Special Government Employee (SGE)
- Arthur F. Harralson Pharm.D.: Associate Dean for Academic Affairs, Shenandoah University School of Pharmacy
- Committee Member (Performer): Special Government Employee (SGE)
- Gregory L. Kearns Ph.D.: Professor of Pediatrics and Pharmacology, Children's Mercy Hospitals and Clinics
- Committee Member (Performer): Special Government Employee (SGE)
- Juan J.L. Lertora M.D., Ph.D: Director, Clinical Pharmacology Program
- Committee Member (Performer): Regular Government Employee (RGE)
- Donald E. Mager Ph.D.: Assistant Professor of Pharmaceutical Sciences, University of Buffalo, SUNY
- Committee Member (Performer): Special Government Employee (SGE)
- Dr Philip Mayer PhD: Wyeth Research
- Committee Member (Performer): Representative
- Howard L. McLeod Pharm.D.: Director, Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill
- Committee Member (Performer): Special Government Employee (SGE)
- Fernando J Muzzio Ph.D: Professor of Chemical Engineering, Department of Chemical and Biochemistry, Rutgers University
- Committee Member (Performer): Special Government Employee (SGE)
- Harriet B Nembhard Ph.D.: Associate Professor, Pennsylvania State University
- Committee Member (Performer): Special Government Employee (SGE)
- James E. Polli Ph.D.: Professor and Vice-Chair
- Committee Member (Performer): Special Government Employee (SGE)
- Mary V. Relling Pharm.D.: Chair, Pharmaceutical Department, St. Jude Children's Research Hospital
- Committee Member (Performer): Special Government Employee (SGE)
- Anne Skaja Robinson PhD: Associate Professor, University of Delaware
- Committee Member (Performer): Special Government Employee (SGE)
- Fadia T. Shaya Ph.D., MPH: Associate Professor, University of Maryland School of Pharmacy, Dept. of Pharmaceutical Health Services Research
- Committee Member (Performer): Special Government Employee (SGE)
- Dr Richard Stec, Jr PhD: Hospira, Inc.
- Committee Member (Performer): Representative
- Elizabeth M. Topp Ph.D.: Head, Department of Industrial and Physical Pharmacy, Purdue University
- Committee Member (Performer): Special Government Employee (SGE)
- Dr Patricia Tway PhD: CMC Technical Navigator
- Committee Member (Performer): Representative
- Jurgen Venitz M.D., Ph.D: Assoicate Professor, Virginia Commonwealth University School of Pharmacy, Department of Pharmaceutics
- Committee Member (Performer): Special Government Employee (SGE)
|
|